This bill requires insurers and health care plans to follow specific rules when using virtual credit cards or fee-based digital payment methods to reimburse healthcare providers. Insurers must first notify providers of any potential fees, offer a fee-free payment alternative, and get the provider's written consent within 30 days to use the fee-based method. If a provider doesn't respond in time, insurers must default to the fee-free option. The law applies directly to insurers and healthcare providers who contract with them, ensuring transparency and preventing unexpected charges for providers.
This bill establishes legal confidentiality for conversations between police officers and peer support specialists during official counseling sessions. It directly affects law enforcement officers seeking mental health support and the peer support specialists who provide it. Key provisions prohibit disclosing session details unless there's a specific threat of suicide, self-harm, violence, or child abuse - allowing limited disclosure only to prevent harm. Officers must receive written notice before sessions explaining these confidentiality rules and exceptions. The law ensures peer support communications remain private except in clearly defined safety emergencies.
This bill (A 9491) requires courts and mental health institutions to coordinate discharge planning for defendants in criminal cases terminated due to mental disease or defect. It mandates that courts order referrals to community services (when clinically appropriate and with consent) and dismiss charges upon termination, while institutions must track referrals and submit de-identified annual reports to state officials. The mental hygiene law office must publish annual public data on defendant outcomes, including admission rates, discharge planning, and referral patterns. The bill directly affects defendants in such cases, courts, mental health facilities, and state agencies, without altering eligibility for services or requiring referrals where consent is absent.
Relates to requiring a medical facility or related service to obtain express prior written consent before filming and/or broadcasting of visual images of a patient's medical treatment.
Refers individuals to appropriate service providers that are able to provide services to such individual within seventy-two hours for substance use disorders.
S 3029 establishes a licensing system for genetic counselors in New York and creates a State Board for Genetic Counseling. To practice as a genetic counselor or use the title "genetic counselor," individuals must obtain a license by meeting requirements including a master's degree in genetic counseling, passing an exam, and demonstrating relevant experience. The bill prohibits unlicensed practice and restricts the title to licensed professionals, while defining genetic counseling as providing education about genetic risks and testing - without diagnosing or treating medical conditions. The State Board, composed of five licensed genetic counselors, one physician, and one public representative, will oversee licensing standards and professional conduct. This directly affects genetic counselors seeking to practice in New York and ensures consistent educational and professional standards for the public.
Relates to program eligibility for plans comparable to Medicare part D; provides for analysis of health plans by the department of health to determine whether such health plans meet or exceed the Medicare part D standard; requires the department of health, in consultation with the department of financial services, to notify prescription drug insurers of the provisions of this act.
Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities including the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).
This bill creates a certification process for organizations providing in-home substance use disorder treatment services in New York. It requires applicants (including out-of-state entities registered with the state) to meet specific clinical standards, including conducting screenings for overdose risk, mental health conditions, and suicide risk. Certified providers must implement safety plans, medication-assisted treatment, naloxone access, and regular recovery planning. The law aims to standardize and expand access to in-home treatment while ensuring providers meet defined safety and clinical requirements.
Establishes an intensive addiction and medical services integrated services pilot program to support two three-year demonstration programs that provide intensive addiction and medical services integrated services to individuals who have significant addiction and medical issues.
